In this study, we applied the oncolytic recombinant NDV (rNDV) to induce cell-mediated immunity in treated patients and succeeded to achieve the oncolytic activity together with the production of canine IFNγ by rNDV-cIFNγ infection. This evidence concerns the gene IFNG and infection.